<VariationArchive VariationID="843202" VariationName="NM_033629.6(TREX1):c.416del (p.Ala139fs)" VariationType="Deletion" Accession="VCV000843202" Version="9" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-03-05" DateCreated="2020-04-15" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="828240" VariationID="843202">
      <GeneList>
        <Gene Symbol="ATRIP" FullName="ATR interacting protein" GeneID="84126" HGNC_ID="HGNC:33499" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>3p21.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="48446737" stop="48467645" display_start="48446737" display_stop="48467645" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="48488113" stop="48507053" display_start="48488113" display_stop="48507053" Strand="+" />
          </Location>
          <OMIM>606605</OMIM>
        </Gene>
        <Gene Symbol="ATRIP-TREX1" FullName="ATRIP-TREX1 readthrough" GeneID="111822955" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>3p21.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="48446779" stop="48467645" display_start="48446779" display_stop="48467645" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="TREX1" FullName="three prime repair exonuclease 1" GeneID="11277" HGNC_ID="HGNC:12269" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>3p21.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="48465830" stop="48467645" display_start="48465830" display_stop="48467645" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="48506918" stop="48509043" display_start="48506918" display_stop="48509043" Strand="+" />
          </Location>
          <OMIM>606609</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_033629.6(TREX1):c.416del (p.Ala139fs)</Name>
      <CanonicalSPDI>NC_000003.12:48467070:C:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>3p21.31</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="48467071" stop="48467071" display_start="48467071" display_stop="48467071" variantLength="1" positionVCF="48467070" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="48508470" stop="48508470" display_start="48508470" display_stop="48508470" variantLength="1" positionVCF="48508469" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>A129fs</ProteinChange>
      <ProteinChange>A139fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.48508470del" Assembly="GRCh37">
            <Expression>NC_000003.11:g.48508470del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.48467071del" Assembly="GRCh38">
            <Expression>NC_000003.12:g.48467071del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009820.2" sequenceAccession="NG_009820" sequenceVersion="2" change="g.6242del">
            <Expression>NG_009820.2:g.6242del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033100.1" sequenceAccession="NG_033100" sequenceVersion="1" change="g.38790del">
            <Expression>NG_033100.1:g.38790del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_041782.1" sequenceAccession="NG_041782" sequenceVersion="1" change="g.25362del">
            <Expression>NG_041782.1:g.25362del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_153405.1" sequenceAccession="NR_153405" sequenceVersion="1" change="n.3725del">
            <Expression>NR_153405.1:n.3725del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_007248.5" sequenceAccession="NM_007248" sequenceVersion="5" change="c.386del">
            <Expression>NM_007248.5:c.386del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_009179.2" sequenceAccession="NP_009179" sequenceVersion="2" change="p.Ala129fs">
            <Expression>NP_009179.2:p.Ala129fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_033629.6" sequenceAccession="NM_033629" sequenceVersion="6" change="c.416del" MANESelect="true">
            <Expression>NM_033629.6:c.416del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_338599.1" sequenceAccession="NP_338599" sequenceVersion="1" change="p.Ala139fs">
            <Expression>NP_338599.1:p.Ala139fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001271023.2" sequenceAccession="NM_001271023" sequenceVersion="2" change="c.*1517del">
            <Expression>NM_001271023.2:c.*1517del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_032166.4" sequenceAccession="NM_032166" sequenceVersion="4" change="c.*1517del">
            <Expression>NM_032166.4:c.*1517del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_130384.3" sequenceAccession="NM_130384" sequenceVersion="3" change="c.*1517del" MANESelect="true">
            <Expression>NM_130384.3:c.*1517del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_282" sequenceAccession="LRG_282">
            <Expression>LRG_282:g.6242del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_282t1" sequenceAccession="LRG_282t1">
            <Expression>LRG_282t1:c.416del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_282p1" sequenceAccession="LRG_282p1" change="p.Ala139fs">
            <Expression>LRG_282p1:p.Ala139fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_033629.2" sequenceAccession="NM_033629" sequenceVersion="2" change="c.416del">
            <Expression>NM_033629.2:c.416del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="763229085" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00003" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00003" Source="Trans-Omics for Precision Medicine (TOPMed)" />
        <AlleleFrequency Value="0.00004" Source="Exome Aggregation Consortium (ExAC)" />
        <AlleleFrequency Value="0.00004" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00008" Source="NHLBI Exome Sequencing Project (ESP) Exome Variant Server" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_033629.6(TREX1):c.416del (p.Ala139fs) AND multiple conditions" Accession="RCV001045764" Version="4">
        <ClassifiedConditionList TraitSetID="12753">
          <ClassifiedCondition DB="MedGen" ID="C0796126">Aicardi-Goutieres syndrome 1</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0024145">Chilblain lupus 1</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1860518">Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-30" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_033629.6(TREX1):c.416del (p.Ala139fs) AND not provided" Accession="RCV001567593" Version="4">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-06-20" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_033629.6(TREX1):c.416del (p.Ala139fs) AND multiple conditions" Accession="RCV002282434" Version="1">
        <ClassifiedConditionList TraitSetID="79700">
          <ClassifiedCondition DB="MedGen" ID="C0796126">Aicardi-Goutieres syndrome 1</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0751587">Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0024145">Chilblain lupus 1</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1860518">Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2022-06-04" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-30" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2020-04-15" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16845398</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19344873</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26633542</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26938784</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29387804</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31719132</ID>
        </Citation>
        <DescriptionHistory Dated="2023-02-02">
          <Description>Pathogenic/Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2021-09-23">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="12753" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="141" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">CREE ENCEPHALITIS</ElementValue>
                <XRef Type="MIM" ID="225750" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ENCEPHALOPATHY, FAMILIAL INFANTILE, WITH INTRACRANIAL CALCIFICATION AND CHRONIC CEREBROSPINAL FLUID LYMPHOCYTOSIS</ElementValue>
                <XRef Type="MIM" ID="225750" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PSEUDOTOXOPLASMOSIS SYNDROME</ElementValue>
                <XRef Type="MIM" ID="225750" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Aicardi-Goutieres syndrome 1</ElementValue>
                <XRef ID="MONDO:0009165" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">AGS1</ElementValue>
                <XRef Type="MIM" ID="225750" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">AGS</ElementValue>
                <XRef Type="MIM" ID="225750" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10893" />
                <XRef ID="10893" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Most characteristically, Aicardi-Goutières syndrome (AGS) manifests as an early-onset encephalopathy that usually, but not always, results in severe intellectual and physical disability. A subgroup of infants with AGS present at birth with abnormal neurologic findings, hepatosplenomegaly, elevated liver enzymes, and thrombocytopenia, a picture highly suggestive of congenital infection. Otherwise, most affected infants present at variable times after the first few weeks of life, frequently after a period of apparently normal development. Typically, they demonstrate the subacute onset of a severe encephalopathy characterized by extreme irritability, intermittent sterile pyrexias, loss of skills, and slowing of head growth. Over time, as many as 40% develop chilblain skin lesions on the fingers, toes, and ears. It is becoming apparent that atypical, sometimes milder, cases of AGS exist, and thus the true extent of the phenotype associated with pathogenic variants in the AGS-related genes is not yet known.</Attribute>
                <XRef ID="NBK1475" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15167" />
                <XRef ID="15167" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301648</ID>
                <ID Source="BookShelf">NBK1475</ID>
              </Citation>
              <XRef ID="51" DB="Orphanet" />
              <XRef ID="C0796126" DB="MedGen" />
              <XRef ID="MONDO:0009165" DB="MONDO" />
              <XRef Type="MIM" ID="225750" DB="OMIM" />
            </Trait>
            <Trait ID="6104" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Cerebroretinal vasculopathy, hereditary</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Retinopathy, vascular, with cerebral and renal involvement and Raynaud and migraine phenomena</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations</ElementValue>
                <XRef ID="MONDO:0008641" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Vasculopathy, retinal, with cerebral leukodystrophy</ElementValue>
                <XRef ID="Vasculopathy%2C+retinal%2C+with+cerebral+leukodystrophy/7360" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">RVCL</ElementValue>
                <XRef ID="GTR000553865" DB="Genetic Testing Registry (GTR)" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">RVCLS</ElementValue>
                <XRef Type="MIM" ID="192315" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CRV</ElementValue>
                <XRef Type="MIM" ID="192315" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">TREX1-Related Retinal Vasculopathy with Cerebral Leukoencephalopathy and Systemic Manifestations</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S) is a small-vessel disease that affects highly vascularized tissues including the retina, brain, liver, and kidneys. Age of onset is often between 35 and 50 years. The most common presenting finding is decreased visual acuity and/or visual field defects. Neurologic manifestations may include hemiparesis, facial weakness, aphasia, and hemianopsia. Migraines and seizures are less frequently described. Renal manifestations may include mild-to-moderate increase in serum creatinine and mild proteinuria; progression to end-stage renal disease (ESRD) is uncommon. Hepatic manifestations frequently include mildly elevated levels of alkaline phosphatase and gamma-glutamyltransferase (GGT). Less common findings include psychiatric disorders, hypertension, mild-to-moderate anemia, and Raynaud phenomenon.</Attribute>
                <XRef ID="NBK546576" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1217" />
                <XRef ID="1217" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">31536185</ID>
                <ID Source="BookShelf">NBK546576</ID>
              </Citation>
              <XRef ID="247691" DB="Orphanet" />
              <XRef ID="3421" DB="Orphanet" />
              <XRef ID="63261" DB="Orphanet" />
              <XRef ID="71291" DB="Orphanet" />
              <XRef ID="C1860518" DB="MedGen" />
              <XRef ID="MONDO:0008641" DB="MONDO" />
              <XRef Type="MIM" ID="192315" DB="OMIM" />
            </Trait>
            <Trait ID="1425" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Chilblain lupus 1</ElementValue>
                <XRef ID="MONDO:0012500" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CHBL1</ElementValue>
                <XRef Type="MIM" ID="610448" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18493" />
                <XRef ID="18493" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C0024145" DB="MedGen" />
              <XRef ID="MONDO:0012500" DB="MONDO" />
              <XRef Type="MIM" ID="610448" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="79700" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="141" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">CREE ENCEPHALITIS</ElementValue>
                <XRef Type="MIM" ID="225750" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ENCEPHALOPATHY, FAMILIAL INFANTILE, WITH INTRACRANIAL CALCIFICATION AND CHRONIC CEREBROSPINAL FLUID LYMPHOCYTOSIS</ElementValue>
                <XRef Type="MIM" ID="225750" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PSEUDOTOXOPLASMOSIS SYNDROME</ElementValue>
                <XRef Type="MIM" ID="225750" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Aicardi-Goutieres syndrome 1</ElementValue>
                <XRef ID="MONDO:0009165" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">AGS1</ElementValue>
                <XRef Type="MIM" ID="225750" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">AGS</ElementValue>
                <XRef Type="MIM" ID="225750" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10893" />
                <XRef ID="10893" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Most characteristically, Aicardi-Goutières syndrome (AGS) manifests as an early-onset encephalopathy that usually, but not always, results in severe intellectual and physical disability. A subgroup of infants with AGS present at birth with abnormal neurologic findings, hepatosplenomegaly, elevated liver enzymes, and thrombocytopenia, a picture highly suggestive of congenital infection. Otherwise, most affected infants present at variable times after the first few weeks of life, frequently after a period of apparently normal development. Typically, they demonstrate the subacute onset of a severe encephalopathy characterized by extreme irritability, intermittent sterile pyrexias, loss of skills, and slowing of head growth. Over time, as many as 40% develop chilblain skin lesions on the fingers, toes, and ears. It is becoming apparent that atypical, sometimes milder, cases of AGS exist, and thus the true extent of the phenotype associated with pathogenic variants in the AGS-related genes is not yet known.</Attribute>
                <XRef ID="NBK1475" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15167" />
                <XRef ID="15167" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301648</ID>
                <ID Source="BookShelf">NBK1475</ID>
              </Citation>
              <XRef ID="51" DB="Orphanet" />
              <XRef ID="C0796126" DB="MedGen" />
              <XRef ID="MONDO:0009165" DB="MONDO" />
              <XRef Type="MIM" ID="225750" DB="OMIM" />
            </Trait>
            <Trait ID="6104" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Cerebroretinal vasculopathy, hereditary</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Retinopathy, vascular, with cerebral and renal involvement and Raynaud and migraine phenomena</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations</ElementValue>
                <XRef ID="MONDO:0008641" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Vasculopathy, retinal, with cerebral leukodystrophy</ElementValue>
                <XRef ID="Vasculopathy%2C+retinal%2C+with+cerebral+leukodystrophy/7360" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">RVCL</ElementValue>
                <XRef ID="GTR000553865" DB="Genetic Testing Registry (GTR)" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">RVCLS</ElementValue>
                <XRef Type="MIM" ID="192315" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CRV</ElementValue>
                <XRef Type="MIM" ID="192315" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">TREX1-Related Retinal Vasculopathy with Cerebral Leukoencephalopathy and Systemic Manifestations</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S) is a small-vessel disease that affects highly vascularized tissues including the retina, brain, liver, and kidneys. Age of onset is often between 35 and 50 years. The most common presenting finding is decreased visual acuity and/or visual field defects. Neurologic manifestations may include hemiparesis, facial weakness, aphasia, and hemianopsia. Migraines and seizures are less frequently described. Renal manifestations may include mild-to-moderate increase in serum creatinine and mild proteinuria; progression to end-stage renal disease (ESRD) is uncommon. Hepatic manifestations frequently include mildly elevated levels of alkaline phosphatase and gamma-glutamyltransferase (GGT). Less common findings include psychiatric disorders, hypertension, mild-to-moderate anemia, and Raynaud phenomenon.</Attribute>
                <XRef ID="NBK546576" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1217" />
                <XRef ID="1217" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">31536185</ID>
                <ID Source="BookShelf">NBK546576</ID>
              </Citation>
              <XRef ID="247691" DB="Orphanet" />
              <XRef ID="3421" DB="Orphanet" />
              <XRef ID="63261" DB="Orphanet" />
              <XRef ID="71291" DB="Orphanet" />
              <XRef ID="C1860518" DB="MedGen" />
              <XRef ID="MONDO:0008641" DB="MONDO" />
              <XRef Type="MIM" ID="192315" DB="OMIM" />
            </Trait>
            <Trait ID="43267" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy</ElementValue>
                <XRef ID="MONDO:0007432" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS125310" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CASIL</ElementValue>
                <XRef Type="MIM" ID="125310" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy</ElementValue>
                <XRef ID="CADASIL/1013" DB="Genetic Alliance" />
                <XRef ID="390936003" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CADASIL</ElementValue>
                <XRef Type="MIM" ID="125310" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1049" />
                <XRef ID="1049" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy) is characterized by mid-adult onset of recurrent ischemic stroke, cognitive decline progressing to dementia, a history of migraine with aura, mood disturbance, apathy, and diffuse white matter lesions and subcortical infarcts on neuroimaging.</Attribute>
                <XRef ID="NBK1500" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301673</ID>
                <ID Source="BookShelf">NBK1500</ID>
              </Citation>
              <Citation Type="general" Abbrev="BSH, 2022">
                <ID Source="PubMed">35645034</ID>
              </Citation>
              <XRef ID="C0751587" DB="MedGen" />
              <XRef ID="MONDO:0007432" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS125310" DB="OMIM" />
            </Trait>
            <Trait ID="1425" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Chilblain lupus 1</ElementValue>
                <XRef ID="MONDO:0012500" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CHBL1</ElementValue>
                <XRef Type="MIM" ID="610448" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18493" />
                <XRef ID="18493" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C0024145" DB="MedGen" />
              <XRef ID="MONDO:0012500" DB="MONDO" />
              <XRef Type="MIM" ID="610448" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5027473" SubmissionDate="2022-09-12" DateLastUpdated="2022-09-17" DateCreated="2022-09-17">
        <ClinVarSubmissionID localKey="NM_033629.6:c.416del|MedGen:C0751587;C0796126;C0024145;C1860518" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002571717" DateUpdated="2022-09-17" DateCreated="2022-09-17" Type="SCV" Version="1" SubmitterName="Institute of Neurology, Charite University of Medicine" OrgID="508609" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-06-04">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TREX1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_033629.6:c.416del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0751587" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0796126" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0024145" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1860518" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12003103</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3515662" SubmissionDate="2023-06-28" DateLastUpdated="2023-07-01" DateCreated="2021-08-19">
        <ClinVarSubmissionID localKey="GDXSV:277452" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV001791308" DateUpdated="2023-07-01" DateCreated="2021-08-19" Type="SCV" Version="2" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Published functional studies demonstrate a a significant decrease in enzymatic activity (McGlasson et al., 2017); Frameshift variant predicted to result in protein truncation, as the last 176 amino acids are replaced with 20 different amino acids, and other loss-of-function variants have been reported downstream in the Human Gene Mutation Database (HGMD); This variant is associated with the following publications: (PMID: 26633542, 31719132, 26938784, 16845398, 29387804, 30219631, 27943079)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TREX1" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:63275</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_033629.2:c.416del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_200_20230628054203</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_24_20210817091645</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2374932" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="4843293|MedGen:C1860518;C0796126;C0024145" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001209635" DateUpdated="2024-02-28" DateCreated="2020-04-15" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">19344873</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26633542</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31719132</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29387804</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16845398</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26938784</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Ala139Valfs*21) in the TREX1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 176 amino acid(s) of the TREX1 protein. This variant is present in population databases (rs763229085, gnomAD 0.007%). This premature translational stop signal has been observed in individual(s) with clinical features of autosomal recessive Aicardi Goutieres syndrome and an unspecified abnormality of the nervous system or stroke (PMID: 19344873, 26633542, 31719132). ClinVar contains an entry for this variant (Variation ID: 843202). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this premature translational stop signal affects TREX1 function (PMID: 29387804). This variant disrupts the C-terminus of the TREX1 protein. Other variant(s) that disrupt this region (p.Arg164*, p.Trp210*) have been observed in individuals with TREX1-related conditions (PMID: 16845398, 26938784). This suggests that this may be a clinically significant region of the protein. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TREX1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.11:g.48508470del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1860518" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0796126" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0024145" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2374932" TraitType="Disease" MappingType="XRef" MappingValue="C0796126" MappingRef="MedGen">
        <MedGen CUI="C0796126" Name="Aicardi-Goutieres syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5027473" TraitType="Disease" MappingType="XRef" MappingValue="C0796126" MappingRef="MedGen">
        <MedGen CUI="C0796126" Name="Aicardi-Goutieres syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3515662" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5027473" TraitType="Disease" MappingType="XRef" MappingValue="C1860518" MappingRef="MedGen">
        <MedGen CUI="C1860518" Name="Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2374932" TraitType="Disease" MappingType="XRef" MappingValue="C0024145" MappingRef="MedGen">
        <MedGen CUI="C0024145" Name="Chilblain lupus 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5027473" TraitType="Disease" MappingType="XRef" MappingValue="C0024145" MappingRef="MedGen">
        <MedGen CUI="C0024145" Name="Chilblain lupus 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5027473" TraitType="Disease" MappingType="XRef" MappingValue="C0751587" MappingRef="MedGen">
        <MedGen CUI="C0751587" Name="Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2374932" TraitType="Disease" MappingType="XRef" MappingValue="C1860518" MappingRef="MedGen">
        <MedGen CUI="C1860518" Name="Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

